Pathophysiological role and diuretic efficacy of atrial natriuretic peptide in renal patients

被引:0
|
作者
DeNicola, L
Bellizzi, V
Cianciaruso, B
Minutolo, R
Colucci, G
Balletta, M
Fuiano, G
Conte, G
机构
[1] UNIV NAPLES 1,SCH MED,DIV NEPHROL,NAPLES,ITALY
[2] UNIV REGGIO CALABRIA,CATANZARO,ITALY
[3] UNIV NAPLES 2,NAPLES,ITALY
来源
关键词
HEART-FAILURE; PLASMA-LEVELS; SODIUM; HUMANS; GLOMERULONEPHRITIS; MECHANISM; INFUSION; THERAPY; STAGE;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
It has been suggested that renal disease is characterized by the presence of resistance to the natriuretic effects of atrial peptide (ANP). In this study, plasma ANP (pANP) and renal function were evaluated during stepwise infusion of low ANP doses (2, 4, 8, and 16 ng/kg per min) in glomerulonephritic patients with (CRF) or without (GN) moderate renal failure, and in normal subjects (NOR), kept at low-sodium diet (LSD; 35 mEq NaCl/day). To assess the physiological ANP levels, pANP was also measured in the three groups after normal-sodium diet (NSD; 235 mEq NaCl/day). ANP did not affect systemic and renal perfusion at any of the doses tested; a significant increment of GFR was observed only in NOR and GN. The 2-, 4-, and 8-ng/kg doses increased pANP to values overlapping the physiological concentrations measured at NSD; this was associated with a dose-dependent increment of urinary excretion of sodium (UNaV) that reached analogous levels in the three groups. ANP accounted for approximately 40% of the UNaV increment evoked by NSD in patients and in normal subjects. The 16-ng/kg dose led to supraphysiological levels that induced a similar marked enhancement of UNaV (from the basal value of 0.12 +/- 0.02 to 0.42 +/- 0.08 mEq/min in CRF, from 0.13 +/- 0.02 to 0.73 +/- 0.08 in GN, and from 0.09 +/- 0.02 to 0.49 +/- 0.11 in NOR). In CRF, the normal natriuretic response to the highest dose was caused by a larger increase of fractional U,,V that was strictly dependent on the greater pANP increment, as demonstrated by similar changes in the fractional excretion of cGMP, and, in part, on the greater aldosterone decrease. In all groups, ANP also induced a dose-dependent urinary loss of phosphate, potassium, and urea, resulting in a significant 15 to 25% decrease in the plasma levels. Thus, in GN and CRF patients, ANP plays a significant role in the renal handling of sodium; moreover, the achievement of low supraphysiological pANP levels leads to a conspicuous natriuresis associated with unique extranatriuretic effects.
引用
收藏
页码:445 / 455
页数:11
相关论文
共 50 条
  • [1] Physiologic role and diuretic efficacy of atrial natriuretic peptide in health and chronic renal disease
    Conte, G
    Bellizzi, V
    Cianciaruso, B
    Minutolo, R
    Fuiano, G
    DeNicola, L
    KIDNEY INTERNATIONAL, 1997, : S28 - S32
  • [2] PATHOPHYSIOLOGICAL ROLE OF ATRIAL NATRIURETIC PEPTIDE IN MAN
    BUHLER, FR
    MULLER, FB
    RAINE, AEG
    ERNE, P
    KIOWSKI, W
    LINDER, L
    RESINK, TJ
    BOLLI, P
    PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1988, 20 : 35 - 53
  • [3] ATRIAL, NATRIURETIC PEPTIDE - AN ENDOCRINE DIURETIC
    WALDHAUSL, W
    VIERHAPPER, H
    NOWOTNY, P
    KORN, A
    ACTA MEDICA AUSTRIACA, 1986, 13 (4-5) : 126 - 126
  • [4] THE RENAL DOPAMINE SYSTEM MEDIATES THE DIURETIC NATRIURETIC EFFECT OF ATRIAL-NATRIURETIC-PEPTIDE
    PETTERSSON, A
    HEDNER, J
    HEDNER, T
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 (06) : 1323 - 1324
  • [5] EFFICACY OF THE ATRIAL-NATRIURETIC-PEPTIDE (ANP) AS DIURETIC AGENT IN CHRONIC-RENAL-FAILURE (CRF)
    DENICOLA, L
    BELLIZZI, V
    CIANCIARUSO, B
    MINUTOLO, R
    CONTE, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 383 - 383
  • [6] RENAL DENERVATION POTENTIATES THE NATRIURETIC AND DIURETIC EFFECTS OF ATRIAL-NATRIURETIC-PEPTIDE IN ANESTHETIZED RABBITS
    CHRISTY, IJ
    DENTON, KM
    ANDERSON, WP
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1994, 21 (01) : 41 - 48
  • [7] RENAL NERVE BLUNTS NATRIURETIC AND DIURETIC RESPONSE TO ATRIAL-NATRIURETIC-PEPTIDE IN CONSCIOUS RABBITS
    MORITA, H
    NISHIDA, Y
    KANGAWA, K
    MINAMINO, N
    MATSUO, H
    HOSOMI, H
    JAPANESE JOURNAL OF PHYSIOLOGY, 1989, 39 (06): : 931 - 941
  • [8] SECRETORY MECHANISM AND PATHOPHYSIOLOGICAL ROLE OF HUMAN ATRIAL-NATRIURETIC-PEPTIDE IN MEN
    HARA, H
    OGIHARA, T
    SHIMA, J
    SAITO, H
    IINUMA, K
    KUMAHARA, Y
    SAKAI, T
    TATEYAMA, H
    RAKUGI, H
    FUKUI, S
    MINAMINO, T
    KANGAWA, K
    MATUO, H
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1986, 50 (08): : 752 - 753
  • [9] Effect of atrial fibrillation on hematopoietic progenitor cells -: A novel pathophysiological role of the atrial natriuretic peptide?
    Goette, A
    Jentsch-Ullrich, K
    Lendeckel, U
    Röcken, C
    Agbaria, M
    Auricchio, A
    Mohren, M
    Franke, A
    Klein, HU
    CIRCULATION, 2003, 108 (20) : 2446 - 2449
  • [10] The Efficacy of Human Atrial Natriuretic Peptide in Patients with Renal Dysfunction Undergoing Cardiac Surgery
    Izumi, Kenta
    Eishi, Kiyoyuki
    Yamachika, Shiro
    Hashizume, Kouji
    Tada, Seiichi
    Yamane, Kentaro
    Takai, Hideaki
    Tanigawa, Kazuyoshi
    Miura, Takashi
    Nakaji, Shun
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 14 (05) : 294 - 302